EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Adaptive evolution of extensive drug resistance and persistence in epidemic ST11 KPC-producing Klebsiella pneumoniae during antimicrobial chemotherapy

Tinghua Li iD, Yiwei Zhu, Guoxiu Xiang, Ziyang Xu, Haihui Yang, Min Li iD, Zhen Shen iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01235-24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Tinghua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, beta-Lactamases, Klebsiella Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise of carbapenem-resistant Klebsiella pneumoniae , including strains producing K. pneumoniae carbapenemase (KPC) types, poses a significant public health challenge due to their resistance to critical antibiotics. Treatment options for infections caused by KPC-producing K. pneumoniae (KPC-KP) are increasingly limited, particularly as these strains develop resistance to last-line antibiotics such as ceftazidime/avibactam and colistin. This study investigates the evolution of antibiotic resistance and persistence in a series of clonally related ST11 KPC-KP strains isolated from a single patient undergoing extended antimicrobial treatment. The patient, a 47-year-old male with a history of kidney transplantation, developed multiple KPC-KP lung infections during his hospital stay. Resistance to colistin and ceftazidime/avibactam emerged during treatment with these antibiotics. Key resistance mechanisms identified included the integration of IS Kpn26 into mgrB gene, leading to mgrB inactivation and colistin resistance, and the emergence of novel bla KPC-2 variants ( bla KPC-71 and bla KPC-179 ) that confer resistance to ceftazidime/avibactam. Despite the development of colistin resistance in a ceftazidime/avibactam-resistant KPC-KP strain following combination therapy, the patient’s clinical condition significantly improved. Phenotypic assays showed that mgrB disruption in KPC-KP resulted in increased biofilm formation and higher susceptibility to phagocytosis. In mouse models, KPC-KP strains with mgrB disruption showed reduced virulence, increased lung colonization and persistence, and a lower inflammatory response, suggesting that mgrB disruption facilitates the transition from acute infection to colonization. This study highlights the complex interplay between antibiotic resistance and bacterial fitness, offering insights into why some patients experience clinical improvement despite severe drug resistance and incomplete bacterial clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaebeta-LactamasesKlebsiella InfectionsAnti-Bacterial AgentsCeftazidimeBacterial ProteinsColistinMicrobial Sensitivity TestsAzabicyclo CompoundsHumansMaleMiddle AgedAnimalsDrug Resistance, Multiple, BacterialDrug CombinationsMiceBiofilms

Stichwörter der Autor:innen

KPC-producing Klebsiella pneumoniaeMgrBbacterial persistencecolistin resistancevirulence

Substanzen

beta-LactamasesAnti-Bacterial AgentsCeftazidimeBacterial Proteinsavibactam, ceftazidime drug combinationColistincarbapenemaseAzabicyclo CompoundsDrug Combinations

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Laboratory Medicine, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Tinghua Li, Min Li, Zhen Shen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Li, T., Zhu, Y., Xiang, G., Xu, Z., Yang, H., Li, M., & Shen, Z. (2025). Adaptive evolution of extensive drug resistance and persistence in epidemic ST11 KPC-producing Klebsiella pneumoniae during antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01235-24

Vancouver

Li T, Zhu Y, Xiang G, Xu Z, Yang H, Li M, et al. Adaptive evolution of extensive drug resistance and persistence in epidemic ST11 KPC-producing Klebsiella pneumoniae during antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01235-24

BibTeX
@article{Li2025,
  author = {Li, Tinghua and Zhu, Yiwei and Xiang, Guoxiu and Xu, Ziyang and Yang, Haihui and Li, Min and Shen, Zhen},
  title = {Adaptive evolution of extensive drug resistance and persistence in epidemic ST11 KPC-producing Klebsiella pneumoniae during antimicrobial chemotherapy},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01235-24}
}
Kostenlos starten →